Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 500 (ZNF500) is a member of the large zinc finger protein family characterized by the presence of C2H2-type zinc finger motifs, as well as KRAB (Krüppel-associated box) and SCAN protein-protein interaction domains. Zinc finger proteins like ZNF500 primarily function as transcription factors that modulate gene expression by binding specific DNA sequences, thereby regulating chromatin structure and the transcription of target genes[1][2][3]. While the precise biological functions of ZNF500 itself are not well-characterized, members of the ZNF protein family are known to be central to developmental processes, cell differentiation, DNA repair, and maintenance of genome stability[1][3]. Dysregulation of ZNF proteins has been implicated in various diseases, most notably cancers and some neurodevelopmental disorders[1]. However, there are no currently known drugs targeting ZNF500 directly, nor is ZNF500 itself regarded as a validated therapeutic target or biomarker. It is best classified as a transcription factor within the zinc finger protein superfamily[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 500 (ZNF500).